Over the last several years the pharmaceutical industry has come under increased pressure. While many often say the pharmaceutical industry has the most powerful lobby, the truth is many politicians have grown increasingly frustrated with what they characterize as high drug prices; or at least much higher than in virtually every other country around the world. This has led to patents being blamed, with billboards and buses in Washington, DC, wrapped with slogans like “patents kill”.
Recent Posts
- The Impact of Price Controls and Biologics on the Future of U.S. Pharmaceutical Innovation and Investment
- Other Barks & Bites for Friday, June 6: UK House of Lords Insists on Copyright Transparency in AI Bill; OpenAI Vows to Appeal New York Times Ruling; and Stewart Sua Sponte Orders Review of PTAB Win for TikTok
- Squires’ Responses to Senate Judiciary Committee Focus on Balance, Backlog and ‘Born Strong’ Patents
- USPTO Study into Applications with Large Patent Families Raises Questions
- Agency’s Acting Deputy Director Says It’s Back to Basics for the USPTO